🔎 Trials Near Me

Home › Atrial Fibrillation › Tennessee

Atrial Fibrillation clinical trials in Tennessee

12 studies for Atrial Fibrillation are looking for participants at sites in Tennessee.

Cities in Tennessee

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • East Coast Institute for Research, Jefferson City, Jefferson City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07175428

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Tennessee Center for Clinical Trials, Tullahoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  • Jackson-Madison County General Hospital, Jackson
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071

The Fourth Left Atrial Appendage Occlusion Study

  • The University of Tennessee, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  • Tennessee Center for Clinical Trials, Tullahoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

  • Erlanger Medical Center, Chattanooga
Recruiting
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05723926

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

  • Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07298473

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  • Anthos Investigational site 9954, Chattanooga
  • Anthos Investigative Site 9941, Jefferson City
  • Anthos Investigative Site 1056, Memphis
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200

Tracking Results of Ablations to Combat AF Registry Generation 2

  • Jackson Madison County General Hospital, Jackson
  • Centennial Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05111015

BoxX-NoAF Clinical Trial

  • Ascension Saint Thomas, Nashville
RecruitingHealthy volunteers welcome
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT06989775

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • Fort Sanders Regional Medical Center, Knoxville
  • Methodist University Hospital, Memphis
  • Semmes Murphey Main Campus, Memphis
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

  • Vanderbilt University Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06575881

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.